Cell-specific toxicity of fibrates in human embryonal rhabdomyosarcoma cells (Q33186436)

23 July 2017

Cell-specific toxicity of fibrates in human embryonal rhabdomyosarcoma cells (English)

1 reference

embryonal rhabdomyosarcoma

23 July 2017

1 reference

Takayoshi Maiguma

1

1 reference

23 July 2017

Koji Fujisaki

2

1 reference

23 July 2017

Yoshinori Itoh

3

1 reference

23 July 2017

Kazutaka Makino

4

1 reference

23 July 2017

Daisuke Teshima

5

1 reference

23 July 2017

Fumi Takahashi-Yanaga

6

1 reference

23 July 2017

Toshiyuki Sasaguri

7

1 reference

23 July 2017

Ryozo Oishi

8

1 reference

23 July 2017

8 February 2003

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

23 July 2017

1 reference

23 July 2017

367

1 reference

23 July 2017

289-296

1 reference

23 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00210-002-0660-9

23 July 2017

0 references

cites work

Effects of fenofibrate on lipid parameters in obese rhesus monkeys

1 reference

12 December 2020

Rhabdomyolysis and HMG-CoA reductase inhibitors

1 reference

12 December 2020

Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells.

1 reference

12 December 2020

Acute renal failure after cardiopulmonary bypass: a possible association with drugs of the fibrate group

1 reference

12 December 2020

Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia

1 reference

12 December 2020

Statin-fibrate combination therapy

1 reference

12 December 2020

Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase

1 reference

12 December 2020

Pharmacotherapy of hypercholesterolaemia: statins in clinical practice

1 reference

12 December 2020

Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.

1 reference

12 December 2020

Side effects of fibrates (except liver and muscle)

1 reference

12 December 2020

Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore

1 reference

12 December 2020

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

1 reference

12 December 2020

Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.

1 reference

12 December 2020

Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

1 reference

12 December 2020

The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition

1 reference

12 December 2020

Mechanism of action of fibrates on lipid and lipoprotein metabolism

1 reference

12 December 2020

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

1 reference

12 December 2020

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture

1 reference

12 December 2020

Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha.

1 reference

12 December 2020

Rhabdomyolysis: a review of the literature

1 reference

12 December 2020

Effects of HMG-CoA reductase inhibitors on growth and differentiation of cultured rat skeletal muscle cells

1 reference

12 December 2020

8S-lipoxygenase products activate peroxisome proliferator-activated receptor alpha and induce differentiation in murine keratinocytes

1 reference

12 December 2020

Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences

1 reference

12 December 2020

Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins)

1 reference

12 December 2020

A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity

1 reference

12 December 2020

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

12 December 2020

Triglyceride as a risk factor for coronary artery disease.

1 reference

12 December 2020

Lovastatin-induced cytoskeletal reorganization in lens epithelial cells: role of Rho GTPases

1 reference

12 December 2020

Lovastatin-induced apoptosis in prostate stromal cells

1 reference

12 December 2020

PPARalpha ligands and clinical trials: cardiovascular risk reduction with fibrates

1 reference

12 December 2020

Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs.

1 reference

12 December 2020

Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach

1 reference

12 December 2020

Combination drug therapy for combined hyperlipidemia

1 reference

12 December 2020

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

12 December 2020

Severe rhabdomyolysis associated with the cerivastin-gemfibrozil combination therapy: report of a case

1 reference

12 December 2020

10.1007/S00210-002-0660-9

Identifiers

DOI

1 reference

Dimensions Publication ID

23 July 2017

0 references

1 reference